Clinical Trial Update: Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation

View source ↗

Summary

A completed non-interventional, multi-center study evaluated routine inhaled iloprost therapy for pulmonary arterial hypertension delivered via the I-Neb inhala…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ventavis (iloprost)

Snippet

Sponsor: Bayer | Conditions: Pulmonary Hypertension | Status: COMPLETED